The pages of this web site article contain an in depth discussion of a new and highly effective neurotransmitter approach to treating without ADD med use in clinics. This treatment drugs or drug side effects was developed by NeuroResearch Clinics. While on the surface this approach with no ADD med involvement may appear similar to treatment attempted by others in the past, it is differentiated from other approaches by the high degree of effectiveness achieved and the unique way the individual components are used. This approach with no ADD med use was developed by medical doctors caring for medical patients in their clinics while data basing treatment results. If you need assistance in finding a care giver using the NeuroResearch Clinics approach in treatment without ADD med use, we can help. ADD med In the world of ADD med treatment for attention deficit (ADD) there are two groups of drugs prescribed by doctors: Amphetamines Reuptake Inhibitors
Amphetamines as an ADD med have multiple chemical properties, they are reuptake inhibitors and they are neurotoxins (cause permanent brain damage). Of concern with prescription drugs is: Amphetamines are neurotoxic. (Adderall, Vyvanse) Reuptake inhibitors deplete neurotransmitters (Concerta, Ritalin, Strattera, Focalin) Drug side effects (see drugs linked below)
ADD med The ADD med group known as "reuptake inhibitors" include Concerta, Ritalin, Strattera and Focalin. This ADD med group under normal conditions deplete neurotransmitters. The reuptake inhibitor ADD med group shares the problem that they quit working during treatment at some point in time. The reason that the ADD med quits working is because drugs that with neurotransmitters do not work if there is not enough neurotransmitters to work with. When the ADD med quits working it is because neurotransmitter levels have been depleted, by the drug, to levels that are too low to keep the drug working. When one of these drugs quit working the standard approach in medicine is to: increase the drug dosing add a second drug start a new drug
Each of the treatment options above, in using an ADD med in treatment, only serve to deplete neurotransmitter levels in the brain further making the cause of the problem worse. In using an ADD med in treatment it makes the cause of the problem worse, "low neurotransmitter levels". With severe depletion of neurotransmitters the risk of suicide develops. Every ADD med used to treat depression and attention deficit (ADD) carries a suicide warning in their prescribing information. For an in depth discussion of how the ADD med depletes neurotransmitters and induces suicide risk see the links below. Amphetamines ADD med known as Adderall and Vyvanse are amphetamines. All amphetamines are "neurotoxins"' known to cause permanent brain damage. So what does brain damage from an amphetamine ADD med look like? In the upper left column of this web page is a link titled "The Diseases". Click on it and it will take you to a list of neurotransmitter diseases. These are the diseases that can develop on a chronic basis with ADD med use. These diseases usually do not develop while the amphetamine is being taken instead they develop 3 to 5 years after amphetamine ingestion stops. The NeuroResearch Approach Unlike ADD med use in treatment, the approach of NeuroResearch Clinics uses nutrients that build neurotransmitters to levels needed for relief of symptoms. The use of nutrients with neurotransmitter testing is a powerful tool and a unique option to ADD med. Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine instead of an ADD med in order to get these results. Proper use of these simple ingredients in medical treatment is not simple. From time to time a patient will say, "Why do I want to take that, I can go to a health food store and buy it?" People off the street buying in a health food store is like going to an art store and buying a bunch of oil paints then going home and expecting to paint like a mater artist even though there was no previous painting experience. These nutrients have tremendous potential due to their chemical properties. This potential is only fully realized in the hands of the trained professional using neurotransmitter testing. Treatment is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control. The Peer Reviewed Research of NeuroResearch Clinics The ADD med research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression. | 
